[
    [
        {
            "time": "2023-10-10",
            "original_text": "医药生物：中国创新药是否到了国际化的拐点？",
            "features": {
                "keywords": [
                    "医药生物",
                    "中国创新药",
                    "国际化",
                    "拐点"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物：中国创新药是否到了国际化的拐点？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "高瓴资本概念股普遍活跃，广联达、国瓷材料、凯莱英、公牛集团走强",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "广联达",
                    "国瓷材料",
                    "凯莱英",
                    "公牛集团",
                    "走强"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技",
                    "医药",
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股普遍活跃，广联达、国瓷材料、凯莱英、公牛集团走强",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "医药行业政策点评：第四批集采开标在即 持续看好创新药及相关产业链",
            "features": {
                "keywords": [
                    "医药行业",
                    "政策",
                    "第四批集采",
                    "创新药",
                    "产业链"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业政策点评：第四批集采开标在即 持续看好创新药及相关产业链",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "医药生物：CXO景气度持续高涨 重点推荐药明康德、凯莱英等",
            "features": {
                "keywords": [
                    "医药生物",
                    "CXO",
                    "景气度",
                    "药明康德",
                    "凯莱英"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物：CXO景气度持续高涨 重点推荐药明康德、凯莱英等",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]